171 related articles for article (PubMed ID: 22289890)
21. Bioluminescence imaging of bone metastasis in rodents.
Snoeks TJ; van Beek E; Que I; Kaijzel EL; Löwik CW
Methods Mol Biol; 2012; 816():507-15. PubMed ID: 22130947
[TBL] [Abstract][Full Text] [Related]
22. A high-throughput assay for screening natural products that boost NK cell-mediated killing of cancer cells.
Xu Z; Zhu X; Su L; Zou C; Chen X; Hou Y; Gong C; Ng W; Ni Z; Wang L; Yan X; Zhu Y; Jiao X; Yao C; Zhu S
Pharm Biol; 2020 Dec; 58(1):357-366. PubMed ID: 32356467
[No Abstract] [Full Text] [Related]
23. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.
Edinger M; Cao YA; Verneris MR; Bachmann MH; Contag CH; Negrin RS
Blood; 2003 Jan; 101(2):640-8. PubMed ID: 12393519
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
[TBL] [Abstract][Full Text] [Related]
25. Molecular imaging of cell-mediated cancer immunotherapy.
Lucignani G; Ottobrini L; Martelli C; Rescigno M; Clerici M
Trends Biotechnol; 2006 Sep; 24(9):410-8. PubMed ID: 16870284
[TBL] [Abstract][Full Text] [Related]
26. Cancer immunotherapy: sipuleucel-T and beyond.
Hammerstrom AE; Cauley DH; Atkinson BJ; Sharma P
Pharmacotherapy; 2011 Aug; 31(8):813-28. PubMed ID: 21923608
[TBL] [Abstract][Full Text] [Related]
27. High-throughput Imaging as a versatile and unbiased discovery tool.
Pegoraro G; Misteli T
Methods; 2016 Mar; 96():1-2. PubMed ID: 26774352
[No Abstract] [Full Text] [Related]
28. A distinct innate lymphoid cell population regulates tumor-associated T cells.
Crome SQ; Nguyen LT; Lopez-Verges S; Yang SY; Martin B; Yam JY; Johnson DJ; Nie J; Pniak M; Yen PH; Milea A; Sowamber R; Katz SR; Bernardini MQ; Clarke BA; Shaw PA; Lang PA; Berman HK; Pugh TJ; Lanier LL; Ohashi PS
Nat Med; 2017 Mar; 23(3):368-375. PubMed ID: 28165478
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
30. A nanozyme tag enabled chemiluminescence imaging immunoassay for multiplexed cytokine monitoring.
Zhong Y; Tang X; Li J; Lan Q; Min L; Ren C; Hu X; Torrente-Rodríguez RM; Gao W; Yang Z
Chem Commun (Camb); 2018 Dec; 54(98):13813-13816. PubMed ID: 30460939
[TBL] [Abstract][Full Text] [Related]
31. A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology.
Burgess TL; Amason JD; Rubin JS; Duveau DY; Lamy L; Roberts DD; Farrell CL; Inglese J; Thomas CJ; Miller TW
PLoS One; 2020; 15(4):e0226661. PubMed ID: 32240171
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive imaging of cell-mediated therapy for treatment of cancer.
Akins EJ; Dubey P
J Nucl Med; 2008 Jun; 49 Suppl 2(0 2):180S-95S. PubMed ID: 18523073
[TBL] [Abstract][Full Text] [Related]
33. A quantitative study of factors affecting in vivo bioluminescence imaging.
Cui K; Xu X; Zhao H; Wong ST
Luminescence; 2008; 23(5):292-5. PubMed ID: 18452141
[TBL] [Abstract][Full Text] [Related]
34. Novel in vitro protein fragment complementation assay applicable to high-throughput screening in a 1536-well format.
Hashimoto J; Watanabe T; Seki T; Karasawa S; Izumikawa M; Seki T; Iemura S; Natsume T; Nomura N; Goshima N; Miyawaki A; Takagi M; Shin-Ya K
J Biomol Screen; 2009 Sep; 14(8):970-9. PubMed ID: 19641222
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
36. Optical Bioluminescence Protocol for Imaging Mice.
Stout D; David J
Methods Mol Biol; 2018; 1790():29-40. PubMed ID: 29858781
[TBL] [Abstract][Full Text] [Related]
37. Live Cell Bioluminescence Imaging in Temporal Reaction of G Protein-Coupled Receptor for High-Throughput Screening and Analysis.
Hattori M; Ozawa T
Methods Mol Biol; 2016; 1461():195-202. PubMed ID: 27424906
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive bioluminescent and microPET imaging for the regulation of NF-kappaB in human hepatoma-bearing mice.
Chang TJ; Chang YJ; Ho TY; Hsiang CY; Yu CY; Lee TW; Lin WJ; Chang CH
Anticancer Res; 2009 Apr; 29(4):987-94. PubMed ID: 19414336
[TBL] [Abstract][Full Text] [Related]
39. A screening platform for glioma growth and invasion using bioluminescence imaging. Laboratory investigation.
Zhao H; Tang C; Cui K; Ang BT; Wong ST
J Neurosurg; 2009 Aug; 111(2):238-46. PubMed ID: 19199503
[TBL] [Abstract][Full Text] [Related]
40. Acoustic Droplet-Assisted Superhydrophilic-Superhydrophobic Microarray Platform for High-Throughput Screening of Patient-Derived Tumor Spheroids.
Xia Y; Chen H; Li J; Hu H; Qian Q; He RX; Ding Z; Guo SS
ACS Appl Mater Interfaces; 2021 May; 13(20):23489-23501. PubMed ID: 33983701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
